Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets (10mg+500mg)
Overview of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets (10mg+500mg) are a scientifically advanced formulation used for the management of Type 2 Diabetes Mellitus (T2DM). This fixed-dose combination brings together two powerful antidiabetic agents—Dapagliflozin, an SGLT2 inhibitor, and Metformin Hydrochloride, a biguanide—designed to deliver optimal…